Vanguard amends Schedule 13G/A, reports 0 shares in Evolv (NASDAQ: EVLV)
Rhea-AI Filing Summary
Evolv Technologies Holdings Inc: The Vanguard Group filed Amendment No. 3 to a Schedule 13G/A reporting 0 shares beneficially owned of Common Stock, representing 0% of the class as of 03/13/2026.
The filing includes a disclosure that Vanguard completed an internal realignment on 01/12/2026, after which certain subsidiaries report ownership separately in reliance on SEC Release No. 34-39538. The statement is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial stake in EVLV following internal realignment.
The filing states 0 shares beneficially owned and 0% ownership as of 03/13/2026, signalling no current ownership position recorded by the reporting entity for this class.
Because the filing cites the 01/12/2026 internal realignment under SEC Release No. 34-39538, separate subsidiaries now report holdings independently; subsequent filings from Vanguard subsidiaries may show different positions.
Amendment is a routine disclosure tied to reallocation of reporting responsibilities.
The filing aligns with the SEC release allowing disaggregated reporting after internal reorganization; it documents that Vanguard no longer claims beneficial ownership for securities held by those subsidiaries.
Signatory and date are provided (Ashley Grim, 03/26/2026); cash‑flow treatment and any subsidiary holdings are not reported in this amendment.
FAQ
What does Vanguard report for EVLV ownership?
Why does the filing mention an internal realignment?
Does this amendment show any subsidiary holdings in EVLV?
Who signed the Schedule 13G/A amendment for Vanguard?